Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - OPERATING INCOME
Operating Income NBIX - Neurocrine Biosciences, Inc.
251 M
LAST VALUE
12.88%
2 YEAR CAGR
46.73%
5 YEAR CAGR
21.57%
10 YEAR CAGR